Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Mainz biomed b.v. crawled time : 08:00 save search
Mainz Biomed: herausragende Topline-Ergebnisse der ColoFuture-Studie mit innovativen mRNA-Biomarkern – 94% Sensitivität für Darmkrebs, 97% Spezifität und 81% Sensitivität für fortgeschrittene Adenome
Published: 2023-09-13 (Crawled : 08:00) - mainzbiomed.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: 9.02%
H: 9.77%
C: 6.27%
Mainz Biomed gibt strategische Partnerschaft mit Ärztliches Labor Dr. Buhlmann bekannt und erweitert seine Präsenz im deutschen Markt
Published: 2023-09-05 (Crawled : 08:00) - mainzbiomed.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: 0.0%
H: 8.57%
C: 5.21%
Mainz Biomed to Participate in Digestive Disease Week 2023
Published: 2023-05-01 (Crawled : 08:00) - globenewswire.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: -1.76%
H: 5.9%
C: -3.08%
disease week
Mainz Biomed to Commence Quarterly Reporting and Present at Equity Forum Spring Conference 2023 in Frankfurt, Germany
Published: 2023-04-27 (Crawled : 08:00) - globenewswire.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: 15.61%
H: 0.41%
C: 0.0%
conference germany spring
Mainz Biomed Announces Partnership with the Instituto de Microecologia to Expand ColoAlert® Commercialization in Spain and Portugal
Published: 2023-04-26 (Crawled : 08:00) - globenewswire.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: -6.43%
H: 8.12%
C: 8.12%
coloalert partnership commercialization
Mainz Biomed Provides Full Year 2022 Financial Results
Published: 2023-04-10 (Crawled : 08:00) - globenewswire.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: 0.15%
H: 0.0%
C: -6.0%
year financial results
Mainz Biomed Expands Corporate Health Program for ColoAlert with the Addition of Three New Companies in Germany
Published: 2023-04-04 (Crawled : 08:00) - globenewswire.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: -0.56%
H: 4.84%
C: 3.55%
companies health germany program
Mainz Biomed Reports Positive Results from Feasibility Study Evaluating its Portfolio of Novel mRNA Biomarkers for Early Detection of Advanced Colorectal Adenomas
Published: 2023-03-29 (Crawled : 08:00) - globenewswire.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: 5.6%
H: 1.52%
C: -7.95%
mrna positive biomarkers results study
Mainz Biomed to Present at Sidoti Virtual Investor Conference March 22-23
Published: 2023-03-21 (Crawled : 08:00) - globenewswire.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: 7.86%
H: 0.0%
C: -1.67%
conference
Mainz Biomed Announces Partnership with Labor Staber to Expand ColoAlert Commercialization in Germany
Published: 2023-03-15 (Crawled : 08:00) - globenewswire.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: -0.78%
H: 1.04%
C: -1.57%
partnership commercialization germany
Mainz Biomed Appoints Dr. Douglas Rex to its Medical Advisory Board
Published: 2022-09-20 (Crawled : 08:00) - globenewswire.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: 0.47%
H: 1.64%
C: -3.16%
Mainz Biomed Reports First Half 2022 Financial Results
Published: 2022-09-07 (Crawled : 08:00) - globenewswire.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: -0.51%
H: 0.0%
C: -1.7%
financial results
Mainz Biomed to Present at the H.C. Wainwright Annual Global Investment Conference
Published: 2022-09-01 (Crawled : 08:00) - globenewswire.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: 2.39%
H: 0.0%
C: -5.34%
global conference
Mainz Biomed Appoints Dr. D. Kim Turgeon of University of Michigan Health to its Medical Advisory Board
Published: 2022-08-23 (Crawled : 08:00) - globenewswire.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: -0.55%
H: 2.63%
C: -0.44%
health
Mainz Biomed and Dante Genomics Announce Full Commercial Availability of ColoAlert in Italy and the United Arab Emirates
Published: 2022-08-16 (Crawled : 08:00) - globenewswire.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: 13.64%
H: 6.38%
C: 1.33%
commercial genomics
Mainz Biomed Appoints Former QIAGEN Executive Dr. Frank Krieg-Schneider as Vice President of Development
Published: 2022-08-03 (Crawled : 08:00) - globenewswire.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: 0.31%
H: 3.65%
C: 3.23%
Mainz Biomed Appoints Dr. Timothy Wang to Newly Formed Medical Advisory Board
Published: 2022-07-19 (Crawled : 08:00) - globenewswire.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: 0.1%
H: 1.94%
C: 0.61%
Mainz Biomed Today to Provide Corporate Update for First Half of 2022
Published: 2022-07-12 (Crawled : 08:00) - globenewswire.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: 4.33%
H: 3.89%
C: -6.31%
update today
Mainz Biomed Provides Corporate Update for First Half of 2022
Published: 2022-07-05 (Crawled : 08:00) - globenewswire.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: -3.94%
H: 5.76%
C: 1.11%
update
Mainz Biomed Enrolls First Patient in ColoFuture Study Evaluating Integration of Novel mRNA Biomarkers into ColoAlert
Published: 2022-06-28 (Crawled : 08:00) - globenewswire.com
MYNZ | $0.89 -1.55% 18K
|
|
| O: 0.61%
H: 5.85%
C: 2.32%
integration mrna biomarkers
Gainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0606 68.33% 250M
|
CHRO | $1.73 41.22% 46K
|
n/a
ZCMD | $1.98 36.55% 27M
|
Commercial Services
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.304 25.57% 47M
|
Manufacturing
WISA 4 | $7.19 22.07% 18M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
PRTG | $0.285 18.75% 170K
|
Mining, Quarrying, and Oil and ...
Your saved searches
Save your searches and get alerts when important news are released.